ES2189736T3 - Derivados de la benzamida y medicamentos que los contienen. - Google Patents

Derivados de la benzamida y medicamentos que los contienen.

Info

Publication number
ES2189736T3
ES2189736T3 ES00902050T ES00902050T ES2189736T3 ES 2189736 T3 ES2189736 T3 ES 2189736T3 ES 00902050 T ES00902050 T ES 00902050T ES 00902050 T ES00902050 T ES 00902050T ES 2189736 T3 ES2189736 T3 ES 2189736T3
Authority
ES
Spain
Prior art keywords
benzamide
derivatives
medicines containing
formula
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00902050T
Other languages
English (en)
Inventor
Hideo Kato
Noriyuki Kado
Jun Sakaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2189736T3 publication Critical patent/ES2189736T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Abstract

Un compuesto representado por la siguiente fórmula general: **(Fórmula)** en la que R representa un grupo alquilo de 3 a 6 átomos de carbono, o una de sus sales.
ES00902050T 1999-02-04 2000-02-02 Derivados de la benzamida y medicamentos que los contienen. Expired - Lifetime ES2189736T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2703099 1999-02-04

Publications (1)

Publication Number Publication Date
ES2189736T3 true ES2189736T3 (es) 2003-07-16

Family

ID=12209686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00902050T Expired - Lifetime ES2189736T3 (es) 1999-02-04 2000-02-02 Derivados de la benzamida y medicamentos que los contienen.

Country Status (28)

Country Link
US (2) US6638951B1 (es)
EP (1) EP1149832B1 (es)
KR (1) KR100775344B1 (es)
CN (1) CN1126738C (es)
AR (1) AR022338A1 (es)
AT (1) ATE230397T1 (es)
AU (1) AU755124B2 (es)
BG (1) BG65512B1 (es)
BR (1) BR0009135A (es)
CA (1) CA2362211C (es)
CO (1) CO5170447A1 (es)
CZ (1) CZ298219B6 (es)
DE (1) DE60001100T2 (es)
DK (1) DK1149832T3 (es)
ES (1) ES2189736T3 (es)
HK (1) HK1044947B (es)
HU (1) HUP0105359A3 (es)
IL (2) IL144525A0 (es)
MX (1) MXPA01007705A (es)
MY (1) MY122570A (es)
NO (1) NO319791B1 (es)
PL (1) PL203831B1 (es)
PT (1) PT1149832E (es)
SK (1) SK285679B6 (es)
TR (1) TR200102082T2 (es)
TW (1) TW527347B (es)
WO (1) WO2000046201A1 (es)
ZA (1) ZA200107244B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2410939C (en) * 2000-06-07 2010-02-16 Aryx Therapeutics Materials and methods for the treatment of gastroesophageal reflux disease
ATE457309T1 (de) 2003-12-23 2010-02-15 Serodus As Modulatoren von peripheren 5-ht-rezeptoren
US8138204B2 (en) 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US7176218B2 (en) 2004-01-07 2007-02-13 Aryx Therapeutics Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
BRPI0615691A8 (pt) * 2005-08-31 2017-08-15 Aryx Therapeutics Inc Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo
EP2027087A2 (en) 2006-05-18 2009-02-25 MannKind Corporation Intracellular kinase inhibitors
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718345D0 (en) 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
JP3104142B2 (ja) * 1991-02-15 2000-10-30 北陸製薬株式会社 ベンズアミド誘導体
TW213460B (es) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5395832A (en) 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
JPH11292846A (ja) 1998-02-10 1999-10-26 Hokuriku Seiyaku Co Ltd ベンズアミド誘導体及びそれを含有する医薬

Also Published As

Publication number Publication date
CZ20012759A3 (cs) 2002-01-16
AR022338A1 (es) 2002-09-04
US6638951B1 (en) 2003-10-28
PT1149832E (pt) 2003-04-30
AU755124B2 (en) 2002-12-05
CZ298219B6 (cs) 2007-07-25
IL144525A (en) 2006-04-10
BR0009135A (pt) 2001-11-27
SK285679B6 (sk) 2007-06-07
AU2324400A (en) 2000-08-25
CA2362211C (en) 2008-11-25
CO5170447A1 (es) 2002-06-27
DK1149832T3 (da) 2003-04-22
HK1044947B (zh) 2004-07-23
IL144525A0 (en) 2002-05-23
NO20013816D0 (no) 2001-08-03
NO20013816L (no) 2001-08-03
MY122570A (en) 2006-04-29
BG105835A (bg) 2002-05-31
ATE230397T1 (de) 2003-01-15
DE60001100D1 (de) 2003-02-06
HUP0105359A3 (en) 2002-12-28
EP1149832A4 (en) 2002-04-10
TR200102082T2 (tr) 2002-01-21
US20040087622A1 (en) 2004-05-06
HK1044947A1 (en) 2002-11-08
ZA200107244B (en) 2002-06-26
HUP0105359A2 (hu) 2002-05-29
CN1339026A (zh) 2002-03-06
KR20010101996A (ko) 2001-11-15
PL203831B1 (pl) 2009-11-30
SK10912001A3 (sk) 2002-02-05
NO319791B1 (no) 2005-09-12
MXPA01007705A (es) 2003-06-24
DE60001100T2 (de) 2003-11-13
EP1149832A1 (en) 2001-10-31
CN1126738C (zh) 2003-11-05
KR100775344B1 (ko) 2007-11-08
PL349133A1 (en) 2002-07-01
BG65512B1 (bg) 2008-10-31
WO2000046201A1 (fr) 2000-08-10
TW527347B (en) 2003-04-11
CA2362211A1 (en) 2000-08-10
EP1149832B1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
DK0931788T3 (da) Metalloproteasehæmmere
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
ES2189365T3 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
AR012603A1 (es) Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis
CO4700523A1 (es) Purin-6-onas bisustituidas en 2,9
ES2167931T3 (es) Derivados bifenilicos sustituidos por un radical aromatico o heteroaromatico y composiciones farmaceuticas y cosmeticas que los contienen.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
AR044175A1 (es) Compuestos de cefemo
CO4520266A1 (es) Derivado de 1,3-oxazin-4-ona, el herbicida que lo contiene y los productos intermedios para prepararlo
CO4650030A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, proceso para su preparacion y producto farmaceutico que los contiene
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR005549A1 (es) Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.
ES2182090T3 (es) Nuevos derivados de pirrol.
AR003093A1 (es) Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion.
CO5070565A1 (es) Inhibicion de las metaloproteasas de matriz por compuestos de fenetilo sustituido y sus composiciones farmaceuticas
AR035489A1 (es) 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos
SV1998000088A (es) Compuestos farmaceuticos
ES2157498T3 (es) Derivados de triazol o sus sales.
ES2189108T3 (es) Nuevas oxazinas dissustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
BR0009856A (pt) Sìntese de 3-amino-3-aril propanoatos
AR048631A1 (es) Derivados de dialcoxi-imidazopiridinas, composiciones farmaceuticas que los contienen y usos,
AR032724A1 (es) Compuestos ester, metodos de control de plagas y aplicaciones de los compuestos ester
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.